Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8333405 | 0.76 | GAA (0.31) | GAASMN1; SMN2 | |
| SCHEMBL4372136 | 0.74 | BRPF1 (0.36) | GAASMN1; SMN2 | |
| SCHEMBL1598178 | 0.74 | GAA (0.31) | GAASMN1; SMN2 | |
| SCHEMBL3120276 | 0.74 | GAA (0.31) | GAASMN1; SMN2 | |
| SCHEMBL8338720 | 0.74 | GAA (0.32) | GAASMN1; SMN2 | |
| SCHEMBL5894079 | 0.72 | TLR9 (0.35) | GAASMN1; SMN2 | |
| SCHEMBL7603127 | 0.72 | — | — | |
| SCHEMBL31672881 | 0.72 | GAA (0.38) | GAASMN1; SMN2 | |
| SCHEMBL7433336 | 0.72 | GAA (0.38) | GAASMN1; SMN2 | |
| SCHEMBL212380 | 0.71 | LMNA (0.38) | GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6277850-B1 | EFFICIENCY, BIOCOMPATIBILITY, TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ABBOTT LABORATORIES | 2001-08-21 | — | — | US | disclosed |
| EP-0906306-A1 | PYRROLYL QUINOXALINDIONES, THEIR PRODUCTION AND USE AS AMPA RECEPTOR ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997049701-A1 | PYRROLYL QUINOXALINDIONES, THEIR PRODUCTION AND USE AS AMPA RECEPTOR ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-31 | — | — | WO | disclosed |